Hims & Hers Health, Inc. SEC filings HIMS

Hims & Hers Health, Inc. has 1,000 filings in SEC EDGAR's recent list, going back to Aug 8, 2022. Its latest annual report, Form ARS, was filed on Apr 28, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 10, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 7, 2026 (officer or director change). The company's fiscal year ends on December 31.

Hims & Hers Health, Inc. SEC filings
Form Description Filed Period
8-K Current report
Officer or director change
Oct 7, 2026 Oct 7, 2026
10-Q Quarterly report Aug 10, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 10, 2026 Aug 10, 2026
8-K Current report
Officer or director change
Jul 17, 2026 Jul 13, 2026
8-K Current report
Material agreement, New debt
Jul 1, 2026 Jun 26, 2026
8-K Current report
Shareholder vote results
Jun 15, 2026 Jun 11, 2026
8-K Current report
Material agreement, New debt, Other events
Jun 2, 2026 May 29, 2026
8-K Current report
Material agreement, New debt, Unregistered share sale
May 21, 2026 May 21, 2026
8-K Current report
Other events
May 19, 2026 May 18, 2026
10-Q Quarterly report May 11, 2026 Mar 31, 2026
8-K Current report
Results of operations
May 11, 2026 May 11, 2026
ARS Annual report to shareholders Apr 28, 2026 Dec 31, 2025
DEFA14A Additional proxy material Apr 28, 2026 —
DEF 14A Proxy statement Apr 28, 2026 Jun 11, 2026
8-K Current report
Regulation FD disclosure
Mar 11, 2026 Mar 9, 2026
S-8 Employee stock plan registration Feb 24, 2026 —
10-K Annual report Feb 23, 2026 Dec 31, 2025
8-K Current report
Results of operations
Feb 23, 2026 Feb 23, 2026
8-K Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
Feb 19, 2026 Feb 19, 2026
8-K Current report
Other events
Nov 17, 2025 Nov 13, 2025
10-Q Quarterly report Nov 3, 2025 Sep 30, 2025
8-K Current report
Results of operations
Nov 3, 2025 Nov 3, 2025
8-K Current report
Officer or director change
Oct 2, 2025 Sep 28, 2025
8-K Current report
Other events
Sep 22, 2025 Sep 22, 2025
8-K Current report
Material agreement
Sep 5, 2025 Sep 1, 2025
10-Q Quarterly report Aug 4, 2025 Jun 30, 2025
8-K Current report
Results of operations, Other events
Aug 4, 2025 Aug 4, 2025
8-K Current report
Shareholder vote results
Jun 17, 2025 Jun 12, 2025
8-K Current report
Material agreement, New debt, Unregistered share sale
May 13, 2025 May 13, 2025
8-K Current report
Other events
May 9, 2025 May 8, 2025
10-Q Quarterly report May 5, 2025 Mar 31, 2025
8-K Current report
Results of operations
May 5, 2025 May 5, 2025
ARS Annual report to shareholders Apr 25, 2025 Dec 31, 2024
DEFA14A Additional proxy material Apr 25, 2025 —
DEF 14A Proxy statement Apr 25, 2025 Dec 31, 2024
8-K Current report
Officer or director change
Apr 21, 2025 Apr 21, 2025
UPLOAD Letter from the SEC Apr 17, 2025 —
CORRESP Letter to the SEC Apr 14, 2025 —
UPLOAD Letter from the SEC Mar 31, 2025 —
S-8 Employee stock plan registration Feb 24, 2025 —
10-K Annual report Feb 24, 2025 Dec 31, 2024
8-K Current report
Results of operations
Feb 24, 2025 Feb 24, 2025
8-K Current report
Officer or director change
Nov 21, 2024 Nov 15, 2024
10-Q Quarterly report Nov 4, 2024 Sep 30, 2024
8-K Current report
Results of operations
Nov 4, 2024 Nov 4, 2024
8-K Current report
Other events
Sep 9, 2024 Sep 5, 2024
424B7 Filing Sep 9, 2024 —
S-3ASR Automatic shelf registration Sep 9, 2024 —
10-Q Quarterly report Aug 5, 2024 Jun 30, 2024
8-K Current report
Results of operations
Aug 5, 2024 Aug 5, 2024
8-K Current report
Officer or director change
Jul 22, 2024 Jul 16, 2024
8-K Current report
Shareholder vote results
Jun 10, 2024 Jun 6, 2024
8-K/A Amended current report
Officer or director change
Jun 6, 2024 Apr 24, 2024
10-Q Quarterly report May 6, 2024 Mar 31, 2024
8-K Current report
Results of operations
May 6, 2024 May 6, 2024
ARS Annual report to shareholders Apr 26, 2024 Dec 31, 2023
8-K Current report
Officer or director change
Apr 26, 2024 Apr 24, 2024
8-K/A Amended current report
Officer or director change
Apr 26, 2024 Mar 30, 2024
DEF 14A Proxy statement Apr 26, 2024 Jun 6, 2024
8-K Current report
Officer or director change
Apr 3, 2024 Mar 30, 2024
S-8 Employee stock plan registration Feb 26, 2024 —
10-K Annual report Feb 26, 2024 Dec 31, 2023
8-K Current report
Results of operations
Feb 26, 2024 Feb 26, 2024
10-Q Quarterly report Nov 6, 2023 Sep 30, 2023
8-K Current report
Results of operations
Nov 6, 2023 Nov 6, 2023
10-Q Quarterly report Aug 7, 2023 Jun 30, 2023
8-K Current report
Results of operations
Aug 7, 2023 Aug 7, 2023
8-K Current report
Shareholder vote results
Jun 7, 2023 Jun 1, 2023
10-Q Quarterly report May 8, 2023 Mar 31, 2023
8-K Current report
Results of operations
May 8, 2023 May 8, 2023
ARS Annual report to shareholders Apr 28, 2023 Dec 31, 2022
DEF 14A Proxy statement Apr 28, 2023 —
S-8 Employee stock plan registration Feb 28, 2023 —
10-K Annual report Feb 27, 2023 Dec 31, 2022
8-K Current report
Results of operations
Feb 27, 2023 Feb 27, 2023
8-K Current report
Officer or director change
Feb 23, 2023 Feb 16, 2023
10-Q Quarterly report Nov 7, 2022 Sep 30, 2022
8-K Current report
Results of operations
Nov 7, 2022 Nov 7, 2022
UPLOAD Letter from the SEC Oct 14, 2022 —
CORRESP Letter to the SEC Oct 11, 2022 —
UPLOAD Letter from the SEC Sep 27, 2022 —
10-Q Quarterly report Aug 8, 2022 Jun 30, 2022
8-K Current report
Results of operations
Aug 8, 2022 Aug 8, 2022

Showing 83 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Services-Offices & Clinics of Doctors of Medicine (SIC 8011)
Listed as
HIMS (NYSE)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
San Francisco, CA
SEC filer status
Large accelerated filer
SEC CIK
1773751
Former names
Oaktree Acquisition Corp. (until Jan 19, 2021)

Other Services-Offices & Clinics of Doctors of Medicine companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.